Testing effectiveness (Phase 2)Study completedNCT00782756
What this trial is testing
Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma
Who this might be right for
Brain CancerMalignant Glioma
Memorial Sloan Kettering Cancer Center 40